"I've known these guys for years. They are the best. They deliver."

- Triangle Insights

Group Client

Engagements focused on therapeutic area, indication, or service offering strategy

Case Study: Oncology Indication Prioritization

Client Situation

An emerging biotech wanted to prioritize development efforts for a potential blockbuster oncology product. The company hired Triangle Insights to refine its development strategy based on a robust understanding of product attributes, commercial and competitive dynamics, and licensing strategy.

Triangle Insights Approach

  • Leadership Team Discussions: Reviewed manuscripts and led client discussions designed to understand the profile of the target product.
  • Secondary Diligence: Synthesized secondary research to refine clinical and commercial understanding of various solid tumors (e.g., Prostate, Lung, Pancreatic, Breast and Ovarian) across relevant lines-of-therapy.
  • Primary Research: Facilitated KOL conversations designed to benchmark the level of unmet need and potential role of target product within identified indications (and lines of treatment).
  • Insights: Developed perspective on technical feasibility, strategic fit, and commercial potential of the various indications.


Client was able to effectively communicate the value of the target product across the various tumor types during licensing discussions. Additionally, the client is pursuing further development of the molecule based on the prioritized target markets.